Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

10776	Companies
232483	Keywords
160951	Articles
123808	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 07/11/2024 at 18:45, 2 years ago

Theranexus publishes its cash position as of 30 June 2024 and presents an update on the progress of Batten-1
Biopharmaceutical company Theranexus announces implementation of new equity line to finance Phase III trial for Batten-1 drug in juvenile Batten disease. Update on Batten-1 program included

Biopharmaceutical Company Phase III Trial Theranexus Batten-1 Equity Line
BRIEF

published on 07/03/2024 at 07:35, 2 years ago

Theranexus, CRNL and CERMEP winners of the Auvergne-Rhône-Alpes “Research Pact 2024” project

Research Neurology Auvergne-Rhône-Alpes Theranexus Neuroimaging
PRESS RELEASE

published on 07/03/2024 at 07:30, 2 years ago

THERANEXUS, LYON NEUROSCIENCE RESEARCH CENTER AND CERMEP WIN THE "2024 RESEARCH PACT" PROJECT FOR THE AUVERGNE-RHÔNE-ALPES REGION
Theranexus, Lyon Neuroscience Research Center, and CERMEP win research pact project 'IMASO' in Auvergne-Rhône-Alpes Region for preclinical neuroimaging in rare neurological diseases

Theranexus Neurological Diseases Research Pact Auvergne-Rhône-Alpes Region Preclinical Neuroimaging
BRIEF

published on 06/06/2024 at 07:35, 2 years 1 month ago

Theranexus and BBDF Announce Positive Results at 18 Months for Batten-1 in Phase 1/2 Study

Theranexus Batten-1 BBDF Batten Disease Neurofilaments
PRESS RELEASE

published on 06/06/2024 at 07:30, 2 years 1 month ago

Theranexus and BBDF confirm positive 18-month results for Batten-1 in Phase I/II trial based on neurofilaments, a biomarker of neuronal death
Theranexus and BBDF confirm positive results in Phase I/II trial evaluating Batten-1 drug for CLN3 Batten disease after 18 months of treatment, showing decline in NfL biomarker levels and therapeutic potential

Theranexus Batten-1 BBDF CLN3 Batten Disease Neurofilament Light Chains
BRIEF

published on 05/02/2024 at 07:35, 2 years 2 months ago

Theranexus unveils its universal registration document for 2023

2023 Biopharmaceutical Universal Registration Document Theranexus Rare Neurological Diseases
BRIEF

published on 04/29/2024 at 18:25, 2 years 2 months ago

Theranexus Reports 2023 Full-Year Results and Details Recent Progress

2023 Financial Results Theranexus Rare Neurological Diseases PickASO Project Batten Disease
PRESS RELEASE

published on 04/29/2024 at 18:20, 2 years 2 months ago

THERANEXUS PUBLISHES ITS 2023 FULL-YEAR RESULTS AND PRESENTS ITS PROGRESS REPORT
Theranexus reports 2023 financial results, cash position, progress report, and the arrival of Christine Placet as CFO. Highlights include positive Batten-1 trial results and funding options for future trials

Financial Results Theranexus Rare Neurological Diseases Christine Placet Batten-1 Trial
BRIEF

published on 04/29/2024 at 18:05, 2 years 2 months ago

Theranexus announces its 2023 annual results and the progress of its projects

Biotechnology 2023 Financial Results Rare Diseases Theranexus Research Phase
BRIEF

published on 04/26/2024 at 18:05, 2 years 3 months ago

Theranexus releases voting rights and capital information for March 2024

Share Capital Voting Rights Biopharmaceutical Neurology Theranexus

Accesswire

Published on 07/29/2026 at 13:30, 14 minutes ago

Audited Annual Statements for the Fiscal Year Ended March 31, 2026
Published on 07/29/2026 at 13:30, 14 minutes ago

Sterling Drills Molybdenum Rich Breccia Below MEPS Discovery Intersecting 57 m of 0.81% CuEq Within a Near-Surface 358 m of 0.50% CuEq Including 8.5 m of 4.74% CuEq
Published on 07/29/2026 at 13:10, 34 minutes ago

Spirit Blockchain Capital Appoints Judy Galvez as Chief Financial Officer and Provides Corporate Update
Published on 07/29/2026 at 13:10, 34 minutes ago

Evergold provides Exploration Update from Golden Lion Project in Toodoggone, British Columbia
Published on 07/29/2026 at 13:00, 44 minutes ago

Lac Jeannine Mine Tailings Reclamation and Restoration Project Produces High-Purity 67% FeT Iron Concentrate

View all ACCESSWIRE

EQS Group

Published on 07/29/2026 at 12:58, 45 minutes ago

EQS-Adhoc: Shelly Group SE: Disclosure of inside information about recent media reports
Published on 07/29/2026 at 12:39, 1 hour 4 minutes ago

EQS-Adhoc: Rheinmetall Aktiengesellschaft: Q2 significantly exceeds market expectations with record revenue growth and earnings
Published on 07/29/2026 at 12:06, 1 hour 37 minutes ago

Holding(s) in Company
Published on 07/29/2026 at 12:05, 1 hour 39 minutes ago

VeroNex VERIFIZIERT™: European AI Verification is Ready
Published on 07/29/2026 at 12:05, 1 hour 39 minutes ago

Lockton Launches Global Data Centers & Digital Infrastructure Practice

Les Echos

Published on 07/29/2026 at 12:05, 1 hour 39 minutes ago

CNP Assurances wins the call for tenders for the personal risk insurance of 62,000 employees of the City of Paris and its partners
Published on 07/29/2026 at 08:30, 5 hours 14 minutes ago

SUEZ delivers a solid first half of 2026
Published on 07/29/2026 at 08:15, 5 hours 29 minutes ago

Winamp Announces Strategic Partnership with Deezer to Power the Next Generation of Its Iconic Music Player
Published on 07/29/2026 at 08:00, 5 hours 44 minutes ago

Neoen doubles size of Goyder Battery after signing two 15-year capacity contracts in South Australia
Published on 07/28/2026 at 19:21, 18 hours 23 minutes ago

Saint-Gobain signs a framework agreement with Microsoft and enhances its leadership in AI for construction

View all LES ECHOS COMFI WIRE